Merck Provides Update on Fda’s Oncologic Drugs Advisory Committee Meeting Discussion of Pd-L1 Expression Levels in Certain Advanced Gastric, Gastroesophageal Junction and Esophageal Cancer Indications
默沙東就FDA的腫瘤藥物顧問委員會會議討論某些晚期胃癌、胃食管交界處癌和食管癌適應症中的PD-L1表達水平提供更新
